CoreCap Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
SRC
CIEC
FIA
YIH
AA
SIM
COPPSERS
CWP
LSERS
CoreCap Advisors's AVNS Position: Q2 2026 in Review
CoreCap Advisors reduced its Avanos Medical (AVNS) stake by 50% in Q2 2026, selling an estimated $234 and leaving 10 shares worth $249. The position accounts for ﹤0.01% of the portfolio, ranked #2981.
CoreCap Advisors first reported a position in AVNS in Q4 2021 and has held it in 13 quarters since. The position peaked at $1K in Q2 2022. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.
- CoreCap Advisors held 10 shares of Avanos Medical worth $249 as of Q2 2026.
- CoreCap Advisors sold 10 Avanos Medical shares in Q2 2026, an estimated $234.
- Avanos Medical made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2981 holding.
- CoreCap Advisors first reported a position in Avanos Medical in Q4 2021 and has held it in 13 quarters since.
- CoreCap Advisors's Avanos Medical position peaked at $1K in Q2 2022.
- 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.